Koyfin Home > Directory > Health Care > Aratana Theraptcs > EBITDA Margin

Aratana Theraptcs EBITDA Margin Chart (PETX)

Aratana Theraptcs annual/quarterly EBITDA Margin from 2016 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Aratana Theraptcs EBITDA Margin for the quarter ending December 12, 2018 was $-152m a -14.36% increase of 22m year over year
  • Aratana Theraptcs EBITDA Margin for the last 12 months ending December 12, 2018 was $-29m a -314.78% increase of 92m year over year
  • Aratana Theraptcs Annual EBITDA Margin for 2018 was $-29m a -376.40% increase of 111m from 2017
  • Aratana Theraptcs Annual EBITDA Margin for 2017 was $-140m a 59.41% decrease of -83m from 2016
  • Aratana Theraptcs Annual EBITDA Margin for 2016 was $-57m
Other Margins & Efficiency Metrics:
  • Aratana Theraptcs Return on Capital % for the quarter ending September 09, 2018 was 18.29 a 181.73% increase of 33.23 year over year
  • Aratana Theraptcs Return on Equity % for the quarter ending September 09, 2018 was 35.00 a 305.07% increase of 106.77 year over year
View Chart On Koyfin

Quarterly PETX EBITDA Margin Data

12/2018$-152m
09/2018$45m
06/2018$-112m
03/2018$-174m
12/2017$-69m
09/2017$-128m
06/2017$-182m
06/2016$66m

Annual PETX EBITDA Margin Data

2018$-29m
2017$-140m
2016$-57m